Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
基本信息
- 批准号:9904675
- 负责人:
- 金额:$ 137.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:Action ResearchAcuteAdvanced DevelopmentAffectAnimal ExperimentsAnimal ModelAnimalsAreaAtmosphereAttenuatedAwarenessBiologicalBiological MarkersCardiovascular DiseasesCause of DeathChemical ExposureChemicalsChemistryChronicCommunitiesCommunity OutreachComplementCost MeasuresCritical PathwaysDataDecision MakingDetectionDevelopmentDevicesDiabetes MellitusDiseaseDisease PathwayEcologyEducation and OutreachEnsureEnvironmentEnvironmental ExposureEpidemicEpidemiologyEtiologyEvaluationExposure toFatty LiverFoundationsFutureGoalsHazardous ChemicalsHazardous SubstancesHazardous Waste SitesHealthHeart DiseasesHumanIncidenceIndustrializationInjuryInvestigationKnowledgeLiver diseasesMass Spectrum AnalysisMeasuresMedicalMetabolismMethodsMolecularMonitorNon-Insulin-Dependent Diabetes MellitusNutritionalNutritional statusObesityPathway interactionsPopulationPostdoctoral FellowPredispositionPrevalencePrivate SectorPublic HealthPublic SectorResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResourcesRiskSamplingScienceSeveritiesSiteSuperfundTechniquesTechnologyTestingTherapeutic InterventionTimeTissue SampleToxic effectToxicity TestsToxicologyTrainingTraining ProgramsTranslational ResearchUniversitiesValidationWorkanimal tissuebasebiobankcardiometabolismcomputer codedata archivedata managementdata sharingeducation resourcesexperienceexposed human populationgraduate studenthuman population studyhuman tissueinnovationinterestmembermetabolomicsmultidisciplinarynew technologynovel markerobesity developmentoutreach programpollutantprogramsremediationrepositoryresilienceresponsesuperfund chemicalsuperfund sitetooltranslational medicinevolatile organic compound
项目摘要
PROJECT SUMMARY (Overall)
This proposal is to establish a Superfund Center at the University of Louisville. This Center will support research
on the cardiometabolic effects of volatile organic chemicals (VOCs) that are of high relevance to the Superfund
Program. Center investigators will conduct mode-of-action research to unravel critical pathways of toxicity and
to identify toxicological end-points (cardiometabolic changes) of chemicals (VOCs) found at Superfund and
related sites. Using high throughput metabolomic and mass spectrometry approaches, animal experiments and
human population studies, Center investigations will aid in the discovery and validation of novel biomarkers of
both exposure and cardiometabolic injury that would lay the foundation for future remediation strategies. These
studies will employ state-of-the-art tools to develop pollutant atmospheres for animal exposure and to measure
unique and sensitive biological endpoints reflective of cardiometabolic injury. In addition, work supported by the
Center will lead to the development of new methods and devices for quantifying atmospheric levels of VOCs that
will employ advanced technologies and offer precise, but low-cost measurements of hazardous waste sites. The
major objectives of the Center are to conduct state-of-the-art research on the cardiometabolic toxicity of VOCs
and to determine how they affect cardiometabolic disease (CMD) prevalence and severity in exposed
populations. These studies will be complemented by mode-of-action mechanistic studies in animals to identify
the molecular and cellular mechanisms that contribute to VOC toxicity. Center investigators will also identify
specific conditions such as nutritional status and obesity and increase susceptibility to VOC toxicity and test
therapeutic interventions that can attenuate acute and chronic cardiometabolic effects of VOC exposures. The
findings of these studies will contribute to both the discovery and the validation of sensitive and robust biomarkers
that could be used to assess the extent of exposure, metabolism and toxicity. Center investigators will create
new technologies for detecting VOCs at low environmental levels to enable future exposure assessment
activities. Senior Center members will educate and train junior investigators, graduate students and post-doctoral
Fellows in the field of environmental science, and promote relevant community awareness and participation to
enhance mutual bidirectional understanding of exposure risk and the health effects of exposure. The findings
and discoveries of the Center will be transferred to affected communities, end users in public and private sectors,
and other stakeholders. For future use and analysis, all samples of human and animal tissues and all data
collected during Center investigations will be stored in a computer-coded biorepository. Collectively, Center
activities will lead to rigorous evaluation and better understanding of the effects of these hazardous chemicals
on obesity, diabetes and cardiovascular disease.
项目概要(总体)
该提案是在路易斯维尔大学建立一个超级基金中心。该中心将支持研究
与超级基金高度相关的挥发性有机化学物质 (VOC) 对心脏代谢的影响
程序。中心研究人员将进行作用模式研究,以揭示毒性和毒性的关键途径。
确定超级基金发现的化学品 (VOC) 的毒理学终点(心脏代谢变化)和
相关网站。使用高通量代谢组学和质谱方法、动物实验和
人口研究,中心调查将有助于发现和验证新的生物标志物
暴露和心脏代谢损伤都将为未来的补救策略奠定基础。这些
研究将采用最先进的工具来开发动物暴露的污染物气氛并测量
反映心脏代谢损伤的独特且敏感的生物学终点。此外,工作得到了
该中心将领导开发量化大气中挥发性有机化合物水平的新方法和设备,
将采用先进技术,对危险废物场提供精确但低成本的测量。这
该中心的主要目标是对挥发性有机化合物的心脏代谢毒性进行最先进的研究
并确定它们如何影响接触者中心脏代谢疾病(CMD)的患病率和严重程度
人口。这些研究将得到动物作用机制研究的补充,以确定
导致 VOC 毒性的分子和细胞机制。中心调查人员还将确定
特定条件,如营养状况和肥胖,以及增加对 VOC 毒性和测试的敏感性
可以减轻 VOC 暴露的急性和慢性心脏代谢影响的治疗干预措施。这
这些研究的结果将有助于敏感和稳健的生物标志物的发现和验证
可用于评估暴露程度、代谢和毒性。中心调查人员将创建
用于检测低环境水平挥发性有机化合物的新技术,以实现未来的暴露评估
活动。高级中心成员将教育和培训初级研究员、研究生和博士后
环境科学领域的研究员,并促进相关社区的意识和参与
加强对暴露风险和暴露对健康影响的相互了解。研究结果
该中心的发现将转移给受影响的社区、公共和私营部门的最终用户,
和其他利益相关者。为了将来的使用和分析,人类和动物组织的所有样本以及所有数据
中心调查期间收集的数据将存储在计算机编码的生物储存库中。集体地,中心
活动将导致严格评估和更好地了解这些危险化学品的影响
关于肥胖、糖尿病和心血管疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjay Srivastava其他文献
Sanjay Srivastava的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjay Srivastava', 18)}}的其他基金
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
9917380 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10533743 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10317034 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10082463 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
项目2——VOCs心脏代谢毒性的分子和细胞机制
- 批准号:
10693804 - 财政年份:2017
- 资助金额:
$ 137.89万 - 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
- 批准号:
10354688 - 财政年份:2017
- 资助金额:
$ 137.89万 - 项目类别:
KC Donnelly Externship–Promotion of Translational/Transdisciplinary Efforts in Graduate & Post-Doctoral Research
KC Donnelly 实习 — 促进研究生的转化/跨学科努力
- 批准号:
10382018 - 财政年份:2017
- 资助金额:
$ 137.89万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 137.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 137.89万 - 项目类别:
Operating Grants














{{item.name}}会员




